PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Alzheimer’s Disease Therapeutics And Diagnostics Market .pdf



Original filename: Alzheimer’s Disease Therapeutics And Diagnostics Market.pdf
Title: Alzheimer’s Disease Therapeutics And Diagnostics Market
Author: Shiva

This PDF 1.5 document has been generated by Microsoft® Word 2010, and has been sent on pdf-archive.com on 16/04/2018 at 12:42, from IP address 183.82.x.x. The current document download page has been viewed 186 times.
File size: 452 KB (11 pages).
Privacy: public file




Download original PDF file









Document preview


RESEARCH REPORT
2017-2023
Alzheimer’s disease Therapeutics and Diagnostics Market
Segmented by Therapeutics, by Diagnostics, and by end user analysis, size, share, growth,
Trends and forecasts 2016-2021

Global Alzheimer’s disease Therapeutics and Diagnostics

Alzheimer’s Disease Therapeutics and Diagnostics Market Study :

Alzheimer’s disease (AD) is the maximum everyday reason of modern dementia in the elderly
population. There has been an exponential boom within the frequency of Alzheimer’s ailment
instances globally, stressing the want to increase an useful treatment to cure it.

Presently, very few therapeutic alternatives are gift within the market and none of them offer a
complete treatment for this condition. Hence, access into the market would offer moneymaking
increase possibilities to the enterprise gamers.

The boom of the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is mainly driven by
way of factors consisting of growing vintage age population, growing R&D funding, excessive
frequency of Alzheimer’s and neurodegenerative diseases, and advanced existence expectancy of
the general population. However, elements such as the astronomical value of remedy and lack of
proper repayment guidelines are preventing the increase of the marketplace.

Alzheimer’s Disease Therapeutics and Diagnostics Market Growth, and Value:

According to the Research Report, the Global Alzheimer’s Disease Therapeutics and Diagnostics
Market is posted by the Market Data Forecast. The marketplace become really worth USD nine.92
billion in 2016 and estimated to be growing at a CAGR of 4.62%, to reach USD 12.43 billion from the
forecast duration 2016 to 2021.

Market Segmentation Analysis:

The Global Alzheimer’s Disease Therapeutics and Diagnostics marketplace is segmented primarily
based on Therapeutics and Diagnostics. The market for Alzheimer’s Disease Therapeutics and
Diagnostics, on the premise of Therapeutics, is segmented into Marketed Drugs and Pipeline Drugs.
Marketed Drugs are in addition segmented into NMDA Receptor Antagonists and Cholinesterase
Inhibitors. Marketed Drugs lead the global market on the idea of Therapeutics due to a big person
base. On the idea of Diagnostics, the global Alzheimer’s Disease Therapeutics and Diagnostics
marketplace are segmented into Computed tomography scan, Electroencephalography, Lumbar
puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. Under this
phase, Computed tomography experiment section leads the worldwide Alzheimer’s Disease
Therapeutics and Diagnostics marketplace. The absence of opportunity imaging tool for brain and
neurological diagnostics is one of the critical reasons for its huge proportion.

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

Market Regional Analysis:
The market has additionally been geographically segmented into North America, Europe, AsiaPacific, Latin America and Middle-East & Africa. North America is anticipated to be the most
important marketplace for Alzheimer’s ailment Therapeutics and Diagnostics because of the growing
prevalence of Alzheimer’s sickness and full-size technological tendencies inside the place. With the
upward thrust in growing older populace inside the growing location of Asia Pacific, this marketplace
is projected to develop at the highest CAGR all through the forecast duration.
Alzheimer’s Disease Therapeutics and Diagnostics Market Key players:
Leading organizations have implemented techniques which includes mergers & acquisitions,
collaborations, and joint ventures to advantage a sturdy foothold inside the marketplace. The
principal agencies dominating the worldwide Alzheimer’s Disease Therapeutics and Diagnostics
market are Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG,
Amarantus Bioscience Holdings, H. Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals,
Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F.
Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals and so on.
Research Report Benefits:








The assessment of the current marketplace in your product or offerings and the future
implications of the marketplace
Addresses the possibilities by using better understanding the marketplace through size
estimates and growth charge analysis to forecast the marketplace for the future
The results of political, economic, social, technological, legal and environmental elements at
the enterprise is analyzed via PESTLE analysis to higher apprehend the components of
strategic control required to comply with the exogenous and endogenous factors
Strategic assessment of the important thing gamers to advantage insights in their
performance allowing access to their product portfolio, financial overall performance and
the strengths of their business strategic trends
Comparative take a look at of the corporations throughout the industry measuring their
performances based totally on marketplace share and latest activities so one can attain
competitive intelligence
Equip you with the facts offering with the investment opportunities within the industry

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

TABLE OF CONTENTS
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

5.1 Therapeutics
5.1.1 Introduction
5.1.2 Marketed Drugs
5.1.2.1 NMDA Receptor Antagonists
5.1.2.2 Cholinesterase Inhibitors
5.1.3 Pipeline Drugs
5.1.4 Y-o-Y Growth Analysis, By Therapeutics
5.1.5 Market Attractiveness Analysis, By Therapeutics
5.1.6 Market Share Analysis, By Therapeutics
5.2 Diagnostics
5.2.1 Introduction
5.2.2 Computed tomography scan
5.2.3 Electroencephalography
5.2.4 Lumbar puncture test
5.2.5 Magnetic resonance imaging
5.2.6 Positron emission tomography
5.2.7 Others
5.2.8 Y-o-Y Growth Analysis, By Diagnostics
5.2.9 Market Attractiveness Analysis, By Diagnostics
5.2.10 Market Share Analysis, By Diagnostics
View Full Report @ https://www.marketdataforecast.com/market-reports/global-alzheimersdisease-therapeutics-and-diagnostics-market-2247/

6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Therapeutics
6.1.3.3 By Diagnostics
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Therapeutics
6.1.4.3 By Diagnostics
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Therapeutics
6.1.5.3 By Diagnostics
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

Get Free Sample Report @ https://www.marketdataforecast.com/market-reports/globalalzheimers-disease-therapeutics-and-diagnostics-market-2247/request-sample
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-alzheimers-diseasetherapeutics-and-diagnostics-market-2247/

7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abbvie Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Pfizer Inc.
8.3 AC Immune SA
8.4 Eisai Co Ltd.
8.5 Allergan PLC
8.6 Novartis AG
8.7 Amarantus Bioscience Holdings
8.8 H. Lundbeck A/S
8.9 Anavex LifeSciencescs

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Global Alzheimer’s disease Therapeutics and Diagnostics

8.10 Avid Radiopharmaceuticals
8.11 Forest Laboratories Inc.
8.12 Axon Neuroscience
8.13 Daiichi Sankyo Co
8.14 TauRx Therapeutics Ltd
8.15 Eli Lilly
8.16 F. Hoffmann La Roche AG
8.17 Johnson & Johnson
8.18 GE Healthcare
8.19 Janssen Pharmaceuticals
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


Related documents


PDF Document alzheimer s disease therapeutics and diagnostics market
PDF Document antiviral drugs market
PDF Document companion diagnostics market
PDF Document aarkstore alzheimers disease pipeline review
PDF Document global alzheimer s disease drugs market
PDF Document aarkstore alpha antitrypsin deficiency pipeline review


Related keywords